SynthesisFrontiers in nutrition2026
Effect of omega-3 supplementation on metabolic and inflammatory markers in adults with HIV infection: a systematic review and meta-analysis.
Synthesis in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: People living with human immunodeficiency virus (HIV) infection frequently exhibit altered lipid profiles and persistent inflammation that contribute to long-term morbidity. Omega-3 fatty acids are commonly recommended in this population, but the magnitude and consistency of their benefits remain uncertain. This study aimed to precisely re-estimate the effects of omega-3 supplementation compared with control on selected metabolic (lipid profile) and inflammatory biomarkers (C-reactive protein, CRP), IL-6, and TNF- Methods: We searched PubMed/MEDLINE, Web of Science, and Scopus databases from 1965 to September 2025 for randomized trials reporting lipid or inflammatory biomarkers in adults with HIV. Eligible studies included participants aged 18 years or older and provided the exact numeric triplets required for reproduction (N, mean change or endpoint, and SD). Risk of bias was assessed using RoB 2. All analyses, figures, funnel plots, Egger and Begg tests, and subgroup tests were reproduced exactly from the investigator-supplied Stata 17.0. To explore heterogeneity, we conducted subgroup analyses and meta-regression analyses using study-level percentages of male participants and follow-up duration in months extracted from the data sheets; outcomes with fewer than 3 usable studies were not pooled. Results: Twenty-one trials supplying the exact numeric triplets met the inclusion criteria, representing 1,118 participants in total. The reproduced pooled analyses included total cholesterol ( Conclusion: In adults with HIV, omega-3 supplementation was associated with small, insignificant increases in HDL-C and meaningful reductions in triglycerides, whereas effects on other lipid fractions were inconsistent. Omega-3 supplementation was associated with a consistent reduction in CRP and modest improvements in other inflammatory biomarkers such as IL-6, while evidence for TNF-
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.